JPMorgan analyst Anupam Rama reiterated an Overweight rating and $15.00 price target on Orchard Therapeutics (NASDAQ: ORTX).The analyst comments "Post ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE